Imatinib plasma levels: correlation with clinical benefit in GIST patients.

Widmer, N.; Decosterd, L.A.; Csajka, C.; Montemurro, M.; Haouala, A.; Leyvraz, S.; Buclin, T.

doi:10.1038/sj.bjc.6605584

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

Details

Download: BIB_EF7EF608D142.P001.pdf (135.48 [Ko])
State: Public
Version: author

Serval ID

serval:BIB_EF7EF608D142

Type

Article: article from journal or magazin.

Publication sub-type

Letter (letter): Communication to the publisher.

Collection

Publications

Institution

UNIL/CHUV

Title

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

Journal

British Journal of Cancer

Author(s)

Widmer N., Decosterd L.A., Csajka C., Montemurro M., Haouala A., Leyvraz S., Buclin T.

ISSN

1532-1827[electronic], 0007-0920[linking]

Publication state

Published

Issued date

2010

Peer-reviewed

Oui

Volume

102

Number

7

Pages

1198-1199

Language

english

Notes

Publication types: Letter

Keywords

Albumins/metabolism, Antineoplastic Agents/blood, Antineoplastic Agents/pharmacokinetics, Dose-Response Relationship, Drug, Gastrointestinal Stromal Tumors/drug therapy, Gastrointestinal Stromal Tumors/genetics, Genotype, Glycoproteins/metabolism, Humans, Piperazines/blood, Piperazines/pharmacokinetics, Pyrimidines/blood, Pyrimidines/pharmacokinetics, Treatment Outcome

URN

urn:nbn:ch:serval-BIB_EF7EF608D1429

OAI-PMH

oai:serval.unil.ch:BIB_EF7EF608D142

DOI

10.1038/sj.bjc.6605584

Pubmed

20179709

Web of science

000276159900018

Open Access

Yes